Pratik Shah, Ph.D., is the current CEO of Design Therapeutics, Inc., having stepped into this role in August 2023 after serving as Executive Chair since 2017. His educational background is solid, with a Bachelor's degree in Biological Sciences from UC...
Pratik Shah, Ph.D., is the current CEO of Design Therapeutics, Inc., having stepped into this role in August 2023 after serving as Executive Chair since 2017. His educational background is solid, with a Bachelor's degree in Biological Sciences from UC Irvine and both a Ph.D. in Biochemistry and an MBA from the University of Chicago. Dr. Shah has extensive experience in the biopharmaceutical industry, including key positions at ARS Pharmaceuticals and Auspex Pharmaceuticals, where he led the company during its acquisition by Teva Pharmaceuticals. In 2023, his total compensation was reported at $560,352, which includes a salary of $360,600 and a bonus of $181,552. Dr. Shah is known for his strategic vision and ability to navigate complex research and development, as shown by the company's performance metrics. He has a history of significant insider trading activity, peaking with trades valued at over $91 million in early 2024, reflecting confidence in the stock. Pratik's leadership reflects a blend of scientific knowledge and business acumen, which is critical for steering the company in the competitive biotech landscape.